PET and SPECT in psychiatry: the past and the future Marco PaganiSara CarlettoLuca Ostacoli Editorial 25 July 2019 Pages: 1985 - 1987
Correction to: 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study Mike SathekgeFrank BruchertseiferAlfred Morgenstern Correction 26 June 2019 Pages: 1988 - 1988
Correction to: Multiple cardiovascular involvements in Behçet’s disease: unique utility of 18F-FDG PET/CT in diagnosis and follow-up Xiao-Ying XiWei GaoMin-Fu Yang Correction 27 June 2019 Pages: 1989 - 1989
Two decades of SPECT/CT – the coming of age of a technology: An updated review of literature evidence Ora IsraelO. PelletF. Giammarile Review Article Open access 04 July 2019 Pages: 1990 - 2012
18F FDG-PET/CT has poor diagnostic accuracy in diagnosing shoulder PJI Thomas Falstie-JensenJ. Langeon behalf of the ROSA study-group Original Article 11 July 2019 Pages: 2013 - 2022
Synergistic application of pulmonary 18F-FDG PET/HRCT and computer-based CT analysis with conventional severity measures to refine current risk stratification in idiopathic pulmonary fibrosis (IPF) Francesco FraioliMaria LyashevaAshley M. Groves Original Article Open access 08 July 2019 Pages: 2023 - 2031
Heart rate reserve is a long-term risk predictor in women undergoing myocardial perfusion imaging Caroline E. GebhardMonika MarędziakCatherine Gebhard Original Article 28 June 2019 Pages: 2032 - 2041
Prospective diagnostic performance of semiconductor SPECT myocardial perfusion imaging: wall thickening analysis reduces the need for an additional prone acquisition Loïc DjailebBenjamin DuboisLaurent M. Riou Original Article 18 July 2019 Pages: 2042 - 2050
[11C]JNJ54173717, a novel P2X7 receptor radioligand as marker for neuroinflammation: human biodistribution, dosimetry, brain kinetic modelling and quantification of brain P2X7 receptors in patients with Parkinson’s disease and healthy volunteers Donatienne Van WeehaegheMichel KooleKoen Van Laere Original Article 26 June 2019 Pages: 2051 - 2064
Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson’s disease patients with impulse control disorders I. Navalpotro-GomezR. Dacosta-AguayoMaria C. Rodriguez-Oroz Original Article 04 July 2019 Pages: 2065 - 2076
[18F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer’s disease Sandra Sanabria BohórquezJan MarikRobby M. Weimer Original Article 28 June 2019 Pages: 2077 - 2089
Longitudinal cognitive decline in mild cognitive impairment subjects with early amyloid-β neocortical deposition Andrea CiarmielloE. GiovanniniA. Tartaglione Original Article 01 July 2019 Pages: 2090 - 2098
Evaluation of pharmacokinetic modeling strategies for in-vivo quantification of tau with the radiotracer [18F]MK6240 in human subjects Nicolas J. GuehlDustin W. WootenMarc D. Normandin Original Article 22 July 2019 Pages: 2099 - 2111
European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma David TaïebRodney J. HicksKarel Pacak Original Article 29 June 2019 Pages: 2112 - 2137
Hybrid PET/MRI in major cancers: a scoping review Anni MorsingMalene Grubbe HildebrandtPoul Flemming Høilund-Carlsen Review Article 02 July 2019 Pages: 2138 - 2151
68Ga-NOTA-Aca-BBN(7-14) PET imaging of GRPR in children with optic pathway glioma Jingjing ZhangYongji TianXiaoyuan Chen Original Article 03 July 2019 Pages: 2152 - 2162
18F-Fluoroethyl-tyrosine uptake is correlated with amino acid transport and neovascularization in treatment-naive glioblastomas Friederike LiescheMathias LukasThomas Pyka Short Communication 09 July 2019 Pages: 2163 - 2168
Prospective evaluation of the performance of [68Ga]Ga-PSMA-11 PET/CT(MRI) for lymph node staging in patients undergoing superextended salvage lymph node dissection after radical prostatectomy Mohammad AbufarajBernhard GrubmüllerMarkus Hartenbach Original Article Open access 29 June 2019 Pages: 2169 - 2177
Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies Heiko KrothFelix OdenAndrew Stephens Original Article Open access 01 July 2019 Pages: 2178 - 2189
Influx rate of 18F-fluoroaminosuberic acid reflects cystine/glutamate antiporter expression in tumour xenografts Kathinka E. PitmanSantosh R. AlluriEirik Malinen Original Article 01 July 2019 Pages: 2190 - 2198
Evaluation of neurotensin receptor 1 as potential biomarker for prostate cancer theranostic use Tingting HeMengzhe WangZibo Li Original Article 01 July 2019 Pages: 2199 - 2207
Dual-phase 18F-FP-CIT PET in corticobasal syndrome underlying AD pathology Jung Han YoonYoung Sil Ahn Image of the Month 04 July 2019 Pages: 2208 - 2209
Multiple cardiovascular involvements in Behçet’s disease: unique utility of 18F-FDG PET/CT in diagnosis and follow-up Xiao-Ying XiWei GaoMin-Fu Yang Image of the Month 03 June 2019 Pages: 2210 - 2211
Exceptional 4-year response to 177Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer Andrei GafitaHui WangMatthias Eiber Image of the Month 04 July 2019 Pages: 2212 - 2213
Galderisi Silvana, DeLisi Lynn E., Borgwardt Stefan (Eds.). Neuroimaging of Schizophrenia and Other Primary Psychotic Disorders. Achievements and Perspectives Luigi Mansi Book Review 03 June 2019 Pages: 2214 - 2215
